Preoperative vs Postoperative Hypofractionated Radiosurgery for Patients With Large Brain Metastases
Phase III Randomized Trial Comparing Preoperative Hypofractionated Radiosurgery (HSRS) to Postoperative Hypofractionated Radiosurgery (HSRS) for Patients With Large Brain Metastases (= 2.1cm) Suitable for Surgical Resection
Istituto Clinico Humanitas
146 participants
Jan 31, 2023
INTERVENTIONAL
Conditions
Summary
This is a phase III randomized trial with the aim to compare preoperative HSRS to postoperative HSRS in patients with large at least one BMs from solid tumors suitable for surgical resection.
Eligibility
Inclusion Criteria9
- Age \>18 years
- Histological or cytological or radiological confirmation of solid tumor malignancy
- Clinical indication for surgical resection of one brain metastasis
- Karnosky performance status (KPS) ≥70
- Controlled or responsive extra cranial metastatic lesions
- Limited brain metastases (1-4 BMs)
- Single metastatic lesion ≥ 2.1 cm in maximum diameter (4 cm3)
- Lesions ≤2 cm conditioning mass effect or neurological deficits or massive edema unresponsive to steroids
- Written informed consent form
Exclusion Criteria7
- Prior WBRT
- KPS \< 70
- Diagnosis of small cell lung cancer (SCLC), germinal cell tumour or Lymphoproliferative disease
- Pregnant women
- Prior open neurosurgery for malignancy
- More than 4 brain metastases
- Patients with incompatibility to perform MRI
Interventions
HSRS converges multiple radiation beams to deliver a single, large dose of radiation to a discrete tumor target with high precision, thereby minimizing radiation dose to the surrounding normal tissue.
Complete surgical resection of brain lesions with adeguate margins.
Locations(9)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05545007